Safety Shot expands R&D into nootropics and sleep aids leveraging Sure Shot technology

BONK, INC.

Company initiating R&D for nootropic and sleep aid product lines, leveraging Sure Shot technology.
Sure Shot lowers blood alcohol content and boosts clarity, energy, and mood.
Global nootropics market ~$6.5B, projected >$14.9B by 2034 (CAGR 8.7%).
Sleep supplement market $6.8B (2023), projected $11.8B by 2034 (CAGR 5.1%).
Prototypes expected later this year; product release in coming months.

item 7.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.